Table 1.
STR analysis of melanoma donor serum and synonymous cell lines ML14, M14 and MDA‐MB‐435S
| Cell Line Name | Amelogenin | CSF1PO | D2S1338 | D3S1358 | D5S818 | D7S820 | D8S1179 | D13S317 | D16S539 | D18S51 | D19S433 | D21S11 | FGA | TH01 | TPOX | vWA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) Donor serum | X,Y | 11 | 19,24 | 14,16 | 11,12 | 8,10 | 13,14 | 11,12 | 9,13 | 13,17 | 14,15 | 30 | 21,26 | 6,7 | 8,11 | 16,18 |
| (2) ML14 | X,Y | 11 | 19,24 | 14,16 | 11,12 | 8,10 | 13,14 | 11,12,13 | 13 | 13,17 | 14,15 | 30 | 21,25,26 | 6,7 | 8,11 | 16,18 |
| (3) M14 | X | 11 | 19,24 | 14,16 | 11,12 | 8,10 | 13 | 12 | 9,13 | 13,17 | 14,15 | 30 | 21 | 6,7 | 8,11 | 16,18 |
| (4) MDA‐MB‐435S | X | 11,12 | 19,24 | 14 | 12 | 8 | 13,14 | 12 | 13 | 13,17 | 14,15 | 30 | 21 | 6,7 | 8,11 | 16,18 |
STR loci were amplified using the ABI Identifiler® kit and include the eight core STR loci recommended for human cell line comparison. Sample or profile sources: (1) Serum from donor of M14 and ML14 cell lines, dated December 21, 1973 (source: JWCI); (2) ML14 lymphoblastoid cells, dated January 9, 1998 (source: JWCI); (3) M14 melanoma cells, dated December 2, 1975 (source: JWCI); and (4) MDA‐MB‐435S cells (source: ATCC, HTB‐129D). See also Supporting Information Table S1, which contains additional STR profiles from publications that correspond to the donor serum sample used here as a reference.